AAAAAA

   
Results: 1-15 |
Results: 15

Authors: DAMIANI D MICHIELI M ERMACORA A RUSSO D FANIN R ZAJA F BARALDO M PEA F FURLANUT M BACCARANI M
Citation: D. Damiani et al., ADJUVANT TREATMENT WITH CYCLOSPORINE-A INCREASES THE TOXICITY OF CHEMOTHERAPY FOR REMISSION INDUCTION IN ACUTE NONLYMPHOCYTIC LEUKEMIA, Leukemia, 12(8), 1998, pp. 1236-1240

Authors: BENETELLO P FURLANUT M FORTUNATO M PEA F BARALDO M
Citation: P. Benetello et al., LEVODOPA AND 3-O-METHYLDOPA IN CEREBROSPINAL-FLUID AFTER LEVODOPA-CARBIDOPA ASSOCIATION, Pharmacological research, 35(4), 1997, pp. 313-315

Authors: BENETELLO P FURLANUT M FORTUNATO M BARALDO M PEA F TOGNON A TESTA G
Citation: P. Benetello et al., ORAL GABAPENTIN DISPOSITION IN PATIENTS WITH EPILEPSY AFTER A HIGH-PROTEIN MEAL, Epilepsia, 38(10), 1997, pp. 1140-1142

Authors: DAMIANI D PEA F MICHIELI M ERMACORA A BARALDO M RUSSO D FANIN R FURLANUT M BACCARANI M
Citation: D. Damiani et al., MULTIDRUG-RESISTANCE MODULATION IN-VIVO - THE EFFECT OF CYCLOSPORINE ALONE OR WITH DEXTRO-VERAPAMIL ON IDARUBICIN PHARMACOKINETICS IN ACUTE-LEUKEMIA, Blood, 90(10), 1997, pp. 804-804

Authors: FURLANUT M BARALDO M GALLA F MARZOCCHI V PEA F
Citation: M. Furlanut et al., CYCLOSPORINE NEPHROTOXICITY IN RELATION TO ITS METABOLISM IN PSORIASIS, Pharmacological research, 33(6), 1996, pp. 349-352

Authors: FURLANUT M BARALDO M PEA F MARZOCCHI V CROATTINO L GALLA F
Citation: M. Furlanut et al., BLOOD-CONCENTRATIONS AND CLINICAL EFFECT OF CYCLOSPORINE IN PSORIASIS, Therapeutic drug monitoring, 18(5), 1996, pp. 544-548

Authors: WU G BARALDO M PEA F COSSETTINI P FURLANUT M
Citation: G. Wu et al., EFFECTS OF DIFFERENT SAMPLING STRATEGIES ON PREDICTIONS OF BLOOD CYCLOSPORINE CONCENTRATIONS IN HEMATOLOGICAL PATIENTS WITH MULTIDRUG-RESISTANCE BY BAYESIAN AND NONLINEAR LEAST-SQUARES METHODS, Pharmacological research, 32(6), 1995, pp. 355-362

Authors: WU G BARALDO M FURLANUT M
Citation: G. Wu et al., CALCULATING PERCENTAGE PREDICTION ERROR - A USERS NOTE, Pharmacological research, 32(4), 1995, pp. 241-248

Authors: DAMIANI D MICHIELI M MICHELUTTI A PEA F BARALDO M FANIN R RUSSO D FURLANUT M BACCARANI M
Citation: D. Damiani et al., P170-RELATED MULTIDRUG-RESISTANCE - ENHANCEMENT OF IDARUBICIN CONTENTIN LEUKEMIC-CELLS WITH CYCLOSPORINE IN-VIVO - A REPORT OF 2 CASES, Leukemia, 9(10), 1995, pp. 1792-1795

Authors: GALLA F MARZOCCHI V CROATTINO L POZ D BARALDO M FURLANUT M
Citation: F. Galla et al., ORAL AND INTRAVENOUS DISPOSITION OF CYCLOSPORINE IN PSORIATIC PATIENTS, Therapeutic drug monitoring, 17(3), 1995, pp. 302-304

Authors: FERRACCIOLI G GUERRA P RIZZI V BARALDO M SALAFFI F FURLANUT M BARTOLI E
Citation: G. Ferraccioli et al., SOMATOMEDIN-C (INSULIN-LIKE GROWTH-FACTOR-1) LEVELS DECREASE DURING ACUTE CHANGES OF STRESS-RELATED HORMONES - RELEVANCE FOR FIBROMYALGIA, Journal of rheumatology, 21(7), 1994, pp. 1332-1334

Authors: FANIN R DAMIANI D MICHIELI M CERNO M CANDONI A MICHELUTTI A BARALDO M RUSSO D FURLANUT M BACCARANI M
Citation: R. Fanin et al., CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA, Experimental hematology, 22(8), 1994, pp. 761-761

Authors: BARALDO M FURLANUT M PURICELLI C
Citation: M. Baraldo et al., NO EFFECT OF CLODRONATE ON CYCLOSPORINE-A BLOOD-LEVELS IN HEART-TRANSPLANT PATIENTS SIMULTANEOUSLY TREATED WITH DILTIAZEM AND AZATHIOPRINE, Therapeutic drug monitoring, 16(4), 1994, pp. 435-435

Authors: FURLANUT M BARALDO M PEA F ALBANESE MC ALBERTINI A PURICELLI C
Citation: M. Furlanut et al., EFFECT OF FLUCTUATIONS OF BLOOD CYCLOSPORINE CONCENTRATIONS ON RENAL-FUNCTION, Transplantation proceedings, 26(5), 1994, pp. 2574-2575

Authors: FANIN R DAMIANI D MICHIELI M CERNO M MICHELUTTI A BARALDO M FURLANUT M BACCARANI M TURA S
Citation: R. Fanin et al., CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR), Blood, 82(10), 1993, pp. 10000538-10000538
Risultati: 1-15 |